MAPT and Alzheimer disease: Furthermore, GSK‐3β can participate in AD pathogenesis by regulating multiple intracellular signaling pathways, interfering with Aβ deposition, tau protein hyperphosphorylation, nerve cell apoptosis, and neuroinflammatory response, and other mechanisms (Figure 4).54